Search MapQuest

Akcea Therapeutics, Inc

22 Boston Wharf Rd Fl 9

Boston, MA 02210

https://www.ionispharma.com

Nimbus Therapeutics is a biotechnology company based in Boston, MA that specializes in drug discovery and development.

With a focus on creating innovative therapies for a variety of diseases, Nimbus Therapeutics utilizes cutting-edge technologies to advance novel treatments through the pipeline.

Generated from their business information

Also at this address

360 Environmental

Bruce Johnson - Tro Jung Brannen Inc

Berkley Investments Ltd

Think Cell

Find related places

Pharmacy

Own this business?

Claim it

See a problem?

You might also like

Drugs acting on the respiratory system, Drugs and drug proprietaries, Testing laboratories

Alexion Pharmaceuticals, Inc

Alexion Pharmaceuticals is engaged in the discovery and development of therapeutic products aimed at treating patients with an array of diseases, including hematologic and cardiovascular disorders, autoimmune diseases and cancer. Alexion's two primary product candidates, pexelizumab and eculizumab, are currently undergoing evaluation in several clinical development programs with the Federal Drug Administration. Alexion is engaged in discovering and developing a pipeline of additional antibody therapeutics targeting severe unmet medical needs, through its wholly owned subsidiary, Alexion Antibody Technologies. During the fiscal year ended July 31, 2005, eculizumab was in Phase III clinical development for treatment of paroxysmal nocturnal hemoglobinuria , a chronic hematologic disease, and pexelizumab was in clinical development for two acute cardiac indications. Alexion is also pursuing additional potential indications for eculizumab and has other product candidates in earlier stages of development. Alexion Pharmaceuticals is based in Cheshire, Conn.

Feathers and feather products, Drugs acting on the respiratory system, Drugs and drug proprietaries

Constellation Pharmaceuticals

Constellation Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, specializing in the development of novel cancer therapies. The company focuses on targeting epigenetic pathways to discover and advance potential treatments for various types of cancer. Utilizing cutting-edge research and technology, Constellation Pharmaceuticals is dedicated to advancing the field of oncology through innovative drug discovery and development. The company's mission is to improve patient outcomes and make a meaningful impact in the fight against cancer. Generated from their business information

Sizes, Drugs acting on the respiratory system, Business services, nec, nec

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

United States›Massachusetts›Boston›Akcea Therapeutics, Inc

Get directions
MapQuest Travel
Route Planner
Print your map
Get help
Search the web
Send feedback

Learn more about our mobile apps.

Enterprise solutions
Claim your business
Developer resources

Jobs
Advertise with us

Terms of use
Privacy policy
Data and licenses
About our ads
Do not sell